SCHWARTZWALD, DAVIDM.D. NPI 1104878594 Clinician
Urology · BOCA RATON, FL
- GENESISCARE USA OF FLORIDA LLC — CAPE CORAL, FL
Group affiliation since 2019
The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.
Year: 2024 · 2023 · 2022 locked column · 2021 locked column · 2020 locked column
Provider overview · all codes · CY2024
The full analytics for this provider
PremiumThe billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.
- Charge, service & beneficiary totals — the disclosed scale, all codes
- Practice profile — focus & reach — top codes by share of services
- Office vs. facility setting mix — place-of-service code split
- Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
- Peer positioning — code breadth — how many codes billed, vs peers
Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.
Notify me at launch → Or see a live example profile →Procedures billed to Medicare Part B (2024)
Medicare Part B FFS · CY2024 · as published by CMS| Code | Description | Volume locked column | Beneficiary-episodes locked column | Avg charge locked column | Avg Medicare payment locked column |
|---|---|---|---|---|---|
| J1071 | Injection, testosterone cypionate, 1 mg | premium | premium | premium | premium |
| J9030 | Bcg live intravesical instillation, 1 mg | premium | premium | premium | premium |
| 51798 | Ultrasound measurement of bladder capacity after voiding | premium | premium | premium | premium |
| 81003 | Automated urinalysis test | premium | premium | premium | premium |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | premium | premium | premium | premium |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | premium | premium | premium | premium |
| 36415 | Insertion of needle into vein for collection of blood sample | premium | premium | premium | premium |
| 96372 | Injection of drug or substance under skin or into muscle | premium | premium | premium | premium |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | premium | premium | premium | premium |
| 64566 | Insertion of lower leg neurostimulator electrode | premium | premium | premium | premium |
| 76872 | Ultrasound scan of pelvic region through rectum | premium | premium | premium | premium |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | premium | premium | premium | premium |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | premium | premium | premium | premium |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | premium | premium | premium | premium |
| 51702 | Simple insertion of temporary bladder tube | premium | premium | premium | premium |
| 51720 | Instillation of anti-cancer drug into bladder | premium | premium | premium | premium |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | premium | premium | premium | premium |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | premium | premium | premium | premium |
| 64561 | Insertion of sacral nerve neurostimulator electrode array | premium | premium | premium | premium |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | premium | premium | premium | premium |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | premium | premium | premium | premium |
| 52224 | Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | premium | premium | premium | premium |
| 55700 | Biopsy of prostate gland | premium | premium | premium | premium |
| 76942 | Ultrasonic guidance for needle placement | premium | premium | premium | premium |
| 54235 | Injection procedure to cause erection | premium | premium | premium | premium |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | premium | premium | premium | premium |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | premium | premium | premium | premium |
| 64590 | Insertion or replacement of peripheral, sacral, or gastric neurostimulator generator or receiver | premium | premium | premium | premium |
| 95972 | Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | premium | premium | premium | premium |
| 0421T | Waterjet destruction of prostrate accessed through the urethra | premium | premium | premium | premium |
| 51701 | Insertion of temporary bladder tube | premium | premium | premium | premium |
| 52240 | Destruction and/or removal of large growth of bladder using an endoscope | premium | premium | premium | premium |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | premium | premium | premium | premium |
These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.